AstraZeneca plc | Access to Medicine Foundation
AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19
Pipeline - AstraZeneca
AstraZeneca US
Private Jet Health and Safety Protocols | National Geographic Expeditions
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine | NEJM
Pakistan allows AstraZeneca shot for under 40s to help its expatriates | Reuters
What science can do
New problems erode confidence in AstraZeneca's vaccine | Science
Vaccines | Free Full-Text | Report of Adverse Effects Following Population-Wide COVID-19 Vaccination: A Comparative Study between Six Different Vaccines in Baja-California, Mexico
AstraZeneca in United States
AstraZeneca's vaccine has 76 percent efficacy—slightly lower than the interim results announced Monday
Astrazeneca Vaccine: Bangladesh wants to produce it locally | The Daily Star
AstraZeneca in United States
US finds COVID-19 Vaccine AstraZeneca safe and effective
AstraZeneca to acquire Neogene for $320 million
Pharma is riding a vaccine high, but reputational risks loom | Financial Times
AstraZeneca US and Health Equity: Today & Tomorrow
